RLM-MD Study

Enroll Now

Type of Study:

Adults 18 years and older with Type 1 or 2 Diabetes and Gastroparesis

Title of Study:

A study to evaluate the safety and efficacy of Relamorelin compared to placebo

Short Title:


Study Length: 52 weeks

Target Age/Sex: 18 years and older, Male and Female


Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Live better, healthier, smarter

Schedule an Appointment